RESTART LIFE SCIEN
HEAL.X
Information Services Corp
ISC
Lombard Street Capital Corp
LSC.P
ONCO-INNOVATIONS
ONCO
ZERO CANDIDA TECHNOLOGIES INC
ZCT
CA Stock MarketDetailed Quotes
EMA Emera Inc
- 54.270
- 0.0000.00%
15min DelayMarket to Open Dec 3 16:00 ET
15.90BMarket Cap24.45P/E (TTM)
0.000High0.000Low0Volume0.000Open54.270Pre Close0.00Turnover55.15052wk High0.00%Turnover Ratio292.90MShares42.89052wk Low2.22EPS TTM15.88BFloat Cap56.666Historical High15.20P/E (Static)292.66MShs Float3.028Historical Low3.57EPS LYR0.00%Amplitude2.87Dividend TTM1.44P/B1Lot Size5.29%Div YieldTTM
Emera Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -12.46%759M | 25.30%624M | 25.61%569M | 145.45%2.24B | 1,107.14%423M | 207.45%867M | 591.67%498M | -24.63%453M | -22.95%913M | -153.16%-42M |
| Net income from continuing operations | -80.51%23M | 234.09%147M | -60.94%225M | 3.57%1.05B | --307M | --118M | 184.62%44M | 52.38%576M | 79.86%1.01B | ---- |
| Operating gains losses | -46.00%-73M | -1,545.45%-159M | 106.15%41M | -879.38%-756M | ---50M | ---50M | -95.85%11M | -602.11%-667M | -68.91%97M | ---- |
| Depreciation and amortization | 9.93%299M | 10.98%293M | 10.85%286M | 10.53%1.06B | --266M | --272M | 17.33%264M | 11.21%258M | 4.81%959M | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --73M | ---- |
| Deferred tax | 52.78%-17M | 119.67%12M | -87.66%19M | -36.18%97M | --40M | ---36M | 17.57%-61M | 77.01%154M | 510.81%152M | ---- |
| Other non cashItems | -86.71%46M | 27.49%320M | -81.98%60M | 177.87%890M | 97.95%-40M | -66.28%346M | 351.00%251M | 377.50%333M | -176.09%-1.14B | -509.06%-1.95B |
| Change In working capital | 24.88%271M | 200.00%11M | 69.15%-62M | 59.40%-95M | 73.89%-100M | -2.25%217M | 94.27%-11M | -268.91%-201M | -53.95%-234M | -71.75%-383M |
| -Change in receivables | 3,200.00%99M | -95.68%6M | -91.51%50M | 202.67%653M | ---78M | --3M | 157.20%139M | 1,353.19%589M | -74.73%-636M | ---- |
| -Change in inventory | 875.00%31M | 58.00%-42M | 66.67%55M | 85.51%-31M | --40M | ---4M | 31.03%-100M | -61.63%33M | -154.76%-214M | ---- |
| -Change in payables and accrued expense | -66.42%46M | 976.92%140M | 63.82%-250M | -227.19%-538M | --3M | --137M | -95.56%13M | -17,175.00%-691M | 46.37%423M | ---- |
| -Change in other current liabilities | 17.28%95M | -47.62%-93M | 162.88%83M | -192.75%-179M | ---65M | --81M | 35.05%-63M | -257.14%-132M | 2,657.14%193M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -12.46%759M | 25.30%624M | 25.61%569M | 145.45%2.24B | 1,107.14%423M | 207.45%867M | 591.67%498M | -24.63%453M | -22.95%913M | -153.16%-42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -24.50%-874M | 126.88%189M | 5.63%-604M | -13.55%-2.92B | -872M | -702M | -35.98%-703M | -24.76%-640M | -10.16%-2.57B | |
| Net PPE purchase and sale | -23.03%-876M | -4.48%-746M | 5.65%-601M | -13.14%-2.94B | ---874M | ---712M | -37.31%-714M | -22.26%-637M | -10.05%-2.6B | ---- |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | -80.00%2M | -27.27%8M | 0.00%-3M | -25.93%20M | --2M | --10M | 266.67%11M | -137.50%-3M | 0.00%27M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -24.50%-874M | 126.88%189M | 5.63%-604M | -13.55%-2.92B | 1.36%-872M | -7.18%-702M | -35.98%-703M | -24.76%-640M | -10.16%-2.57B | -16.93%-884M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 100.43%1M | -387.45%-710M | -288.24%-288M | -39.61%939M | 773M | -234M | -26.49%247M | 256.12%153M | 18.61%1.56B | |
| Net issuance payments of debt | 92.63%-7M | -255.01%-572M | -157.93%-168M | -40.60%1.08B | --517M | ---95M | -4.16%369M | 1,100.00%290M | 67.90%1.82B | ---- |
| Net common stock issuance | 3,650.00%150M | 58.33%19M | 342.86%31M | 53.07%424M | --401M | --4M | -86.21%12M | -88.71%7M | -12.62%277M | ---- |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash dividends paid | -7.91%-150M | -14.29%-152M | -12.69%-151M | -3.55%-554M | ---148M | ---139M | 0.75%-133M | -3.08%-134M | -8.52%-535M | ---- |
| Net other financing activities | 300.00%8M | ---- | ---- | -71.43%-12M | --3M | ---4M | 50.00%-1M | -900.00%-10M | 46.15%-7M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 100.43%1M | -387.45%-710M | -288.24%-288M | -39.61%939M | 8.72%773M | -138.61%-234M | -26.49%247M | 256.12%153M | 18.61%1.56B | 15.05%711M |
| Net cash flow | ||||||||||
| Beginning cash position | 13.73%381M | -8.61%276M | 77.11%588M | -20.38%332M | -50.27%273M | 13.18%335M | -25.25%302M | -20.38%332M | 64.17%417M | 15.34%549M |
| Current changes in cash | -65.22%-114M | 145.24%103M | -850.00%-323M | 360.40%263M | 250.70%324M | -129.61%-69M | 138.53%42M | -240.00%-34M | -161.59%-101M | -264.41%-215M |
| Effect of exchange rate changes | -142.86%-3M | 122.22%2M | 175.00%11M | -143.75%-7M | -350.00%-9M | -65.00%7M | -1,000.00%-9M | 233.33%4M | 1,700.00%16M | ---2M |
| End cash Position | -3.30%264M | 13.73%381M | -8.61%276M | 77.11%588M | 77.11%588M | -50.27%273M | 13.18%335M | -25.25%302M | -20.38%332M | -20.38%332M |
| Free cash from | -175.48%-117M | 43.52%-122M | 82.61%-32M | 58.65%-696M | 82.90%-451M | -88.28%155M | 51.79%-216M | -330.00%-184M | -43.36%-1.68B | -285.67%-2.64B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.